查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1604696

人工淚液市場：按產品類型、應用、交付模式分類 - 2025-2030 年全球預測

Artificial Tears Market by Product Type (Cellulose-derived, Glycerin-derived, Oil-based Emulsion), Application (Contact Lens Moisture, Dry Eye Treatment), Delivery Mode - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年人工淚液市場價值為20.6億美元，預計到2024年將達到22.3億美元，複合年成長率為8.27%，預計到2030年將達到36億美元。

人工淚液市場主要集中在眼睛潤滑和水合作用的產品，主要用於緩解眼睛乾燥和發炎。人工淚液的需求源自於多種情況，例如乾眼症、長時間使用螢幕、老齡化和環境因素。人工淚液的應用範圍已不僅限於簡單的眼睛補水，還包括手術後護理和改善隱形眼鏡使用者的視覺舒適度。最終用戶範圍從個人消費者到醫療機構，涵蓋零售、醫療領域等廣泛領域。關鍵的成長要素包括增加使用可能導致眼睛疲勞的數位設備、更容易患乾眼症的人口老化以及產品配方的創新，例如無防腐劑選項和先進的輸送系統。最近的機會來自於人們對眼睛健康意識的增強和對非處方藥（OTC）產品的需求增加，這凸顯了品牌需要增加在零售店和電子商務管道的影響力。

主要市場統計
基準年[2023] 20.6億美元
預計年份 [2024] 22.3億美元
預測年份 [2030] 36億美元
複合年成長率（%） 8.27%

然而，市場成長面臨挑戰，例如影響消費者信心的產品召回事件以及醫療產品嚴格的監管障礙。與現有製藥公司的競爭和品牌忠誠度也是主要障礙。多功能人工淚液的開發、環保包裝和人工智慧驅動的個人化眼部護理解決方案等領域的創新機會已經成熟。因此，企業應該投資新配方的研發，並利用數位行銷來吸引精通科技的消費者。此外，我們可以透過與醫療保健提供者合作來加強我們的分銷網路。了解監管環境和消費行為的區域差異對於最佳化市場滲透策略至關重要。儘管該市場目前由消費者主導，重點關注北美和亞太地區的成長，但策略性地理擴張和技術投資的結合可以擴大 Masu 的未來成長前景。為了充分利用市場機遇，同時應對獨特的挑戰，公司必須適應永續性趨勢，並優先考慮消費者的眼睛健康教育。

市場動態：揭示快速發展的人工淚液市場的關鍵市場洞察

供需的動態交互作用正在改變人工淚液市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 全球眼部疾病增加
    • 乾眼症盛行率增加
    • 提高早期診斷、早期治療的意識
  • 市場限制因素
    • 人工淚液的短期影響
  • 市場機會
    • 介紹具有更高穩定性的改良人工淚液
    • 大量投資開發創新人工淚液配方
  • 市場挑戰
    • 使用受污染的人工淚液相關的風險

波特五力：開拓人工淚液市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解人工淚液市場的外部影響

外部宏觀環境因素對人工淚液市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解人工淚液市場的競爭狀況

對人工淚液市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣人工淚液市場供應商績效評估

FPNV定位矩陣是評估人工淚液市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製人工淚液市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對人工淚液市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地眼科疾病的發生率正在上升
      • 乾眼症盛行率增加
      • 提高對早期診斷和治療的意識和趨勢
    • 抑制因素
      • 人工淚液的短期影響
    • 機會
      • 介紹具有增強穩定性的改良人工淚液
      • 大力投資開發創新人工淚液配方
    • 任務
      • 使用受污染的人工淚液相關的風險
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章人工淚液市場：依產品類型

  • 源自纖維素
  • 源自甘油
  • 油乳液
  • 聚乙二醇基
  • 丙二醇基
  • 透明質酸鈉基質

第7章 人工淚液市場：依應用分類

  • 隱形眼鏡裡有水
  • 乾眼症治療

第8章 人工淚液市場（以交付方式）

  • 眼藥水
  • 軟膏

第9章美洲人工淚液市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太人工淚液市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲人工淚液市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • AbbVie Inc.
  • Alcon Vision LLC
  • Bausch & Lomb Incorporated
  • Bayer AG
  • Horus Pharma
  • Johnson & Johnson Services, Inc.
  • Nicox SA
  • Novartis AG
  • Novax Pharma
  • Oasis Medical, Inc.
  • OCuSOFT Inc.
  • OmniVision GmbH
  • Otsuka Pharmaceutical Co., Ltd.
  • Prestige Consumer Healthcare Inc.
  • Santen Pharmaceutical Co., Ltd.
  • Scope Ophthalmics Ltd.
  • Shire PLC by Takeda Pharmaceutical Company Limited
  • Similasan Corporation
  • Sun Pharmaceutical Industries, Inc.
  • Taiwan Biotech Co., Ltd.
  • Thea Pharmaceuticals Ltd.
  • URSAPHARM Arzneimittel GmbH
  • Visufarma
  • ZEISS Group
Product Code: MRR-69324464D1AA

The Artificial Tears Market was valued at USD 2.06 billion in 2023, expected to reach USD 2.23 billion in 2024, and is projected to grow at a CAGR of 8.27%, to USD 3.60 billion by 2030.

The artificial tears market focuses on products designed to lubricate and hydrate the eyes, primarily used to alleviate dryness and irritation. The necessity for artificial tears arises from various conditions such as dry eye syndrome, prolonged screen time, aging, and environmental factors. Applications of artificial tears are expanding beyond mere eye hydration to include post-surgery care and enhanced visual comfort for contact lens users. End users range from individual consumers to healthcare facilities, providing broad scope across retail and medical sectors. Key growth influencers include increasing digital device usage leading to eye strain, a growing aging population more susceptible to dry eye conditions, and innovations in product formulations, like preservative-free options and advanced delivery systems. Recent opportunities stem from the rise in awareness about eye health and increased demand for over-the-counter (OTC) products, emphasizing the need for brands to enhance presence in retail and e-commerce channels.

KEY MARKET STATISTICS
Base Year [2023] USD 2.06 billion
Estimated Year [2024] USD 2.23 billion
Forecast Year [2030] USD 3.60 billion
CAGR (%) 8.27%

However, market growth faces challenges such as product recall incidents affecting consumer trust and stringent regulatory hurdles governing medical products. Competition from established pharmaceutical companies and brand loyalty also pose significant barriers. Innovation opportunities are ripe in areas like developing multifunctional artificial tears, eco-friendly packaging, and personalized eye care solutions using AI. Thus, companies should invest in R&D for novel formulations and leverage digital marketing to captivate tech-savvy consumers. Additionally, partnerships with healthcare providers can enhance distribution networks. Understanding regional variances in regulatory landscapes and consumer behaviors is vital for optimizing market penetration strategies. While the market is currently consumer-driven with a growth focus in North America and Asia-Pacific regions, strategic geographic expansions, coupled with investments in technology, can amplify future growth prospects. Businesses must align with sustainability trends and prioritize consumer education about eye health to fully capitalize on market opportunities while addressing inherent challenges.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Artificial Tears Market

The Artificial Tears Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidences of eye disorders worldwide
    • Increasing prevalence of dry eye syndrome
    • Growing awareness and inclination towards early diagnosis and treatment
  • Market Restraints
    • Short-term effects of artificial tears
  • Market Opportunities
    • Introduction of improved artificial tears with enhanced stability
    • Significant investments in developing innovative artificial tear formulations
  • Market Challenges
    • Risk pertaining to the use of contaminated artificial tears

Porter's Five Forces: A Strategic Tool for Navigating the Artificial Tears Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Artificial Tears Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Artificial Tears Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Artificial Tears Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Artificial Tears Market

A detailed market share analysis in the Artificial Tears Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Artificial Tears Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Artificial Tears Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Artificial Tears Market

A strategic analysis of the Artificial Tears Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Artificial Tears Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Alcon Vision LLC, Bausch & Lomb Incorporated, Bayer AG, Horus Pharma, Johnson & Johnson Services, Inc., Nicox S.A., Novartis AG, Novax Pharma, Oasis Medical, Inc., OCuSOFT Inc., OmniVision GmbH, Otsuka Pharmaceutical Co., Ltd., Prestige Consumer Healthcare Inc., Santen Pharmaceutical Co., Ltd., Scope Ophthalmics Ltd., Shire PLC by Takeda Pharmaceutical Company Limited, Similasan Corporation, Sun Pharmaceutical Industries, Inc., Taiwan Biotech Co., Ltd., Thea Pharmaceuticals Ltd., URSAPHARM Arzneimittel GmbH, Visufarma, and ZEISS Group.

Market Segmentation & Coverage

This research report categorizes the Artificial Tears Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Cellulose-derived, Glycerin-derived, Oil-based Emulsion, Polyethylene Glycol-based, Propylene Glycol-based, and Sodium Hyaluronate-based.
  • Based on Application, market is studied across Contact Lens Moisture and Dry Eye Treatment.
  • Based on Delivery Mode, market is studied across Eye Drops and Ointments.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidences of eye disorders worldwide
      • 5.1.1.2. Increasing prevalence of dry eye syndrome
      • 5.1.1.3. Growing awareness and inclination towards early diagnosis and treatment
    • 5.1.2. Restraints
      • 5.1.2.1. Short-term effects of artificial tears
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of improved artificial tears with enhanced stability
      • 5.1.3.2. Significant investments in developing innovative artificial tear formulations
    • 5.1.4. Challenges
      • 5.1.4.1. Risk pertaining to the use of contaminated artificial tears
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Artificial Tears Market, by Product Type

  • 6.1. Introduction
  • 6.2. Cellulose-derived
  • 6.3. Glycerin-derived
  • 6.4. Oil-based Emulsion
  • 6.5. Polyethylene Glycol-based
  • 6.6. Propylene Glycol-based
  • 6.7. Sodium Hyaluronate-based

7. Artificial Tears Market, by Application

  • 7.1. Introduction
  • 7.2. Contact Lens Moisture
  • 7.3. Dry Eye Treatment

8. Artificial Tears Market, by Delivery Mode

  • 8.1. Introduction
  • 8.2. Eye Drops
  • 8.3. Ointments

9. Americas Artificial Tears Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Artificial Tears Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Artificial Tears Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Alcon Vision LLC
  • 3. Bausch & Lomb Incorporated
  • 4. Bayer AG
  • 5. Horus Pharma
  • 6. Johnson & Johnson Services, Inc.
  • 7. Nicox S.A.
  • 8. Novartis AG
  • 9. Novax Pharma
  • 10. Oasis Medical, Inc.
  • 11. OCuSOFT Inc.
  • 12. OmniVision GmbH
  • 13. Otsuka Pharmaceutical Co., Ltd.
  • 14. Prestige Consumer Healthcare Inc.
  • 15. Santen Pharmaceutical Co., Ltd.
  • 16. Scope Ophthalmics Ltd.
  • 17. Shire PLC by Takeda Pharmaceutical Company Limited
  • 18. Similasan Corporation
  • 19. Sun Pharmaceutical Industries, Inc.
  • 20. Taiwan Biotech Co., Ltd.
  • 21. Thea Pharmaceuticals Ltd.
  • 22. URSAPHARM Arzneimittel GmbH
  • 23. Visufarma
  • 24. ZEISS Group

LIST OF FIGURES

  • FIGURE 1. ARTIFICIAL TEARS MARKET RESEARCH PROCESS
  • FIGURE 2. ARTIFICIAL TEARS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ARTIFICIAL TEARS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES ARTIFICIAL TEARS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES ARTIFICIAL TEARS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ARTIFICIAL TEARS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. ARTIFICIAL TEARS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ARTIFICIAL TEARS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ARTIFICIAL TEARS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ARTIFICIAL TEARS MARKET DYNAMICS
  • TABLE 7. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY CELLULOSE-DERIVED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY GLYCERIN-DERIVED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY OIL-BASED EMULSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY POLYETHYLENE GLYCOL-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY PROPYLENE GLYCOL-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SODIUM HYALURONATE-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY CONTACT LENS MOISTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY DRY EYE TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY EYE DROPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES ARTIFICIAL TEARS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 147. ARTIFICIAL TEARS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 148. ARTIFICIAL TEARS MARKET, FPNV POSITIONING MATRIX, 2023